These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5910109)

  • 21. [Seroepidemiology of measles in 1428 people from a copper mine of Chengde City].
    Hao YW
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Oct; 6(5):289-91. PubMed ID: 3836746
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunoglobulins on measles vaccine inoculation or measles virus infection--particularly, on 2-mercaptoethanol sensitive and resistant antibodies.
    Arai M; Nakamura M
    Acta Paediatr Jpn; 1970 Dec; 12(2):9-15. PubMed ID: 4100594
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 24. A serological study of children vaccinated against measles.
    Strauss J; Zdrazílek J; Svandová E; Sejda J; Helcl J
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(4):468-81. PubMed ID: 5391988
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunologic structure of the population characterizing measles susceptibility and its change with massive active immunization].
    Tsipershtein MIa; Shekhter AB
    Zh Mikrobiol Epidemiol Immunobiol; 1972 May; 49(5):39-42. PubMed ID: 5037761
    [No Abstract]   [Full Text] [Related]  

  • 26. WHO-supported comparative studies of attenuated live measles virus vaccines.
    Cockburn WC; Pecenka J; Sundaresan T
    Bull World Health Organ; 1966; 34(2):223-31. PubMed ID: 4161187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trial of a reduced dose of measles vaccine in Nigerian children.
    Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
    Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observation of the protective effect of live measles vaccines in the first year after vaccination.
    Sejda J; Helcl J; Strauss J
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
    [No Abstract]   [Full Text] [Related]  

  • 29. Vaccination against measles in the Canadian Arctic.
    Furesz J; Habgood M
    JAMA; 1966 Jan; 195(5):342-4. PubMed ID: 5951890
    [No Abstract]   [Full Text] [Related]  

  • 30. Measles in children previously vaccinated against measles.
    Lerman SJ; Gold E
    JAMA; 1971 May; 216(8):1311-4. PubMed ID: 4102807
    [No Abstract]   [Full Text] [Related]  

  • 31. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
    Böttiger M; Heller L; Kamensky P; Svanberg B
    Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
    [No Abstract]   [Full Text] [Related]  

  • 32. [A comparative study of live measles vaccines in controlled epidemiologic trials].
    Donchev D; Arabadzhieva Ts; Zhukovets V; Iancheva B
    Vopr Virusol; 1969; 14(1):104-7. PubMed ID: 4894054
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles vaccine potency and sero-conversion rates among infants receiving measles immunization in Ilorin, Kwara State, Nigeria.
    Fowotade A; Okonko IO; Nwabuisi C; Bakare RA; Fadeyi A; Adu FD
    J Immunoassay Immunochem; 2015; 36(2):195-209. PubMed ID: 24825255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low seroconversion rates to measles vaccine among children in Nigeria.
    Adu FD; Akinwolere OA; Tomori O; Uche LN
    Bull World Health Organ; 1992; 70(4):457-60. PubMed ID: 1394778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical and serologic study of 103 children with measles vaccine failure.
    Cherry JD; Feigin RD; Shackelford PG; Hinthorn DR; Schmidt RR
    J Pediatr; 1973 May; 82(5):802-8. PubMed ID: 4698954
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on further attenuated live measles vaccine. V. Immunization test of CAM-A4 measles vaccine on handicapped children.
    Ueda S; Okuno Y; Sakamoto Y
    Biken J; 1970 Sep; 13(3):175-8. PubMed ID: 4249672
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody response and clinical reactions in children given measles vaccine with immunoglobulin.
    Lingam S; Miller CL; Clarke M; Pateman J
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1044-5. PubMed ID: 3083994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of measles immunity after a mass immunization campaign.
    Levitt LP; Case GE; Neil JS; Casey HL; Adler P; Ferreri S; Witte JJ
    Public Health Rep (1896); 1970 Mar; 85(3):261-5. PubMed ID: 4984891
    [No Abstract]   [Full Text] [Related]  

  • 40. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.